drugset / Trial / NCT01151735

C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation

NCT01151735 ↗

Phase 4 Withdrawn Penn State University
RandomizedCrossoverQuadruple-blindTreatment

Summary

The study hypothesis is that treatment of Hereditary Angioedema at the time of prodromal symptoms will decrease morbidity associated with the disease

Timeline

Start
2010-07
Primary completion
2012-07
Completion
2012-07

Outcome

Outcome not reported

Stopped: “PennState would not allow the study to move forward”

Drugs

EvaluationDrugModalityDoseRoute
Comparator C-1-esterase Unknown 1000 iu Intravenous
Comparator C-1-esterase Unknown 1500 iu Intravenous

Indications